Phase I study combining tumor necrosis factor with interferon-alpha and interleukin-2.

Eskander, E D; Harvey, H A; Givant, E; Lipton, A

Eskander, E D; Harvey, H A; Givant, E; Lipton, A.

Affiliation

Eskander ED; Department of Medicine, Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, USA.

Am J Clin Oncol ; 20(5): 511-4, 1997 Oct.

Article in En | MEDLINE | ID: mdl-9345339

Subject(s)

Adjuvants, Immunologic/therapeutic use; Interferon-alpha/therapeutic use; Interleukin-2/therapeutic use; Neoplasms/therapy; Tumor Necrosis Factor-alpha/therapeutic use; Adjuvants, Immunologic/administration & dosage; Adjuvants, Immunologic/adverse effects; Adult; Aged; Ambulatory Care; Anemia/etiology; Arrhythmias, Cardiac/etiology; Cohort Studies; Fatigue/etiology; Feasibility Studies; Female; Fever/etiology; Humans; Infusions, Intravenous; Injections, Intramuscular; Injections, Subcutaneous; Interferon-alpha/administration & dosage; Interferon-alpha/adverse effects; Interleukin-2/administration & dosage; Interleukin-2/adverse effects; Male; Middle Aged; Neoplasm Metastasis; Pulmonary Edema/etiology; Remission Induction; Shivering/immunology; Thrombocytopenia/etiology; Tumor Necrosis Factor-alpha/administration & dosage; Tumor Necrosis Factor-alpha/adverse effects; Weight Loss

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Adjuvants, Immunologic / Interleukin-2 / Tumor Necrosis Factor-alpha / Interferon-alpha / Neoplasms Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1997 Type: Article

Search on Google

XML

PubMed Links